TED-N

N/A

Report date: 2023/07/18 17:25:46

Base Information

Drug NameTED-N
Drug Alias NameTED-N
ClassificationCell and gene therapy > Cell therapy > Source of cells > Embryonic stem cell-derivedCell and gene therapy > Cell therapy > Somatic cell > Neural precursor cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesS.Biomedics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesS.Biomedics Co Ltd
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A